What are the risk factors for Prostate cancer?

['ⵙⵎⴷ ⵜⴰⴱⵔⴰⵜ ⴰⴷ']

ⵎⴰⵜⵜⴰ ⵉⵎⵙⴽⴰⵔⵏ ⵏ ⵓⴱⴰⵢⵢⵓⵕ ⵏ ⵍⴽⵏⵚⵉⵕ ⵏ ⵓⴱⵕⵓⵚⵟⴰⵜ?

1. ⴰⵍⵆⵉⴷⵎⴰⵜ: ⵆⴰⵔⴰⴷ ⵓⴰⵏ ⴾⴰⵏⵛⵢⵔ ⵓⴰⵏ ⴱⵔⵓⵙⴰⵜⵢⵜ ⵉⵋⵋⴰ ⴼⴰⵍ ⴰⵍⵆⵉⴷⵎⴰⵜ, ⴷⴰⵔⴰⵜ ⵎⴰⵈⵈⵓⵔⴰⵏ ⵏ ⵉⵛⵂⵉⴾⵉⵍⴰⵏ ⵉⵍⵍⴰⵏ ⴷⴰⵗ ⵉⵔⴳⴰⵣⴰⵏ ⵓⵉⵏ ⵓⴶⴰⵔ 65 ⵏ ⴰⵓⴰⵜⴰⵉ

2. ⵜⴰⵡⵙⵉⵜ/ ⵜⴰⵡⵙⵉⵜ: ⵉⵔⴳⴰⵣⵏ ⵉⵄⵔⵔⵉⵎⵏ ⵏ ⵍⴰⴼⵔⵉⴽⴰ ⴰⵎⵉⵔⵉⴽⴰⵏⵉⵢⵏ ⵖⵓⵔⵙⵏ ⵜⵉⵍⵉⵜ ⵜⴰⵅⴰⵜⴰⵔⵜ ⵏ ⵓⴱⵓⵖⵍⵓ ⵏ ⵍⴽⵓⵏⵚⵉⵕ ⵏ ⵓⴱⵕⵓⵚⵟⴰⵜ ⵓⴳⴳⴰⵔ ⵏ ⵉⵔⴳⴰⵣⵏ ⵏ ⵜⴰⵡⵙⵉⵜⵉⵏ ⵢⴰⴹⵏ.

3. ⴰⵎⵣⵔⵓⵢ ⵏ ⵜⴰⵡⵊⴰ: ⵉⵔⴳⴰⵣⵏ ⵏⵏⴰ ⵖⵓⵔ ⵉⵍⵍⴰ ⵓⵎⵣⵔⵓⵢ ⵏ ⵜⴰⵡⵊⴰ ⵏ ⵍⴽⵓⵏⵚⵉⵕ ⵏ ⵓⴱⵔⵓⵜⵉⵙⵜ, ⵙⵍⴰⵡⴰⵏ ⴰⴽⴽⵡ ⴱⴰⴱⴰⵙ ⵏⵖⴷ ⵓⵍⵜⵎⴰⵜ ⵖⵓⵔⵙⵏ ⵜⵎⴰⴹⵓⵏⵜ ⴰⴷ, ⵖⵓⵔⵙⵏ ⵜⵉⵍⵉⵜ ⵉⴳⴳⵓⵜⵏ.

4. ⵊⵉⵏⵉⵜⵉⵛⵙ: ⴽⵔⴰ ⵏ ⵉⵎⵓⵜⵜⵉⵢⵏ ⵏ ⵊⵉⵏⵉⵜⵉⵢⵏ ⵉⵜⵜⵓⴽⴽⵓⵙⵏ, ⵣⵓⵏⴷ ⴱⵔⵛⴰ1 ⴷ ⴱⵔⵛⴰ2, ⵖⵉⵏ ⴰⴷ ⵔⵏⵓⵏ ⴰⵙⵓⵔⵙ ⵏ ⵓⴽⵏⵙⵉⵔ ⵏ ⵓⴱⵔⵓⵜⵉⵙⵜ.

5. ⴰⵎⵙⴳⵏⴰⴼ: ⴰⵎⵙⴳⵏⴰⴼ ⵉⵍⴰⵏ ⴰⵟⵟⴰⵙ ⵏ ⵉⵚⵕⵓⴹⵏ ⴷ ⵉⴷⵔⵓⵙⵏ ⴳ ⵜⵢⴰⴼⵓⵜⵉⵏ ⴷ ⵜⵣⴰⵔⴰⵜⵉⵏ ⵉⵖⵢ ⴰⴷ ⵉⵔⵏⵓ ⴰⵙⵓⵔⵙ ⵏ ⵓⴽⵏⵙⵉⵔ ⵏ ⵓⴱⵕⵓⵚⵟⴰⵜ.

6. ⴰⴱⵣⴰⵣ: ⴰⴷⴷⴰⵢ ⵉⴳ ⵓⴽⵙⴰⵢ ⵏ ⵜⴼⴽⴽⴰ ⵏⵖⴷ ⴰⴱⵣⴰⵣ ⵉⵖⵢ ⴰⴷ ⵉⵔⵏⵓ ⴰⵙⵓⵔⵙ ⵏ ⵓⴽⵏⵙⵉⵔ ⵏ ⵓⴱⵔⵓⵜⵉⵙⵜ, ⵙⵍⴰⵡⴰⵏ ⴰⴽⴽⵡ ⵜⴰⵍⵖⵉⵡⵉⵏ ⵜⵉⴱⵓⵖⵍⴰⵏⵉⵏ ⵏ ⵜⵎⴰⴹⵓⵏⵜ.

7. ⴰⵙⵉⴽⴰ: ⴰⵙⵉⴽⴰ ⵉⵖⵢ ⴰⴷ ⵉⵔⵏⵓ ⴰⵙⵓⵔⵙ ⵏ ⵓⴽⵏⵙⵉⵔ ⵏ ⵓⴱⵔⵓⵜⴰⵙⵉⵜ, ⵙⵍⴰⵡⴰⵏ ⴰⴽⴽⵡ ⵜⴰⵍⵖⵉⵡⵉⵏ ⵜⵉⴱⵓⵖⵍⴰⵏⵉⵏ ⵏⵖⴷ ⵜⵉⵏ ⵉⵎⵎⵓⵜⵏ ⵏ ⵜⵎⴰⴹⵓⵏⵜ.

8. ⴰⵙⵎⵉⴷⴷⵉ ⵏ ⵉⴽⵉⵎⵢⴰⵡⵏ: ⴰⵙⵎⵉⴷⴷⵉ ⵏ ⴽⵔⴰ ⵏ ⵉⴽⵉⵎⵢⴰⵡⵏ, ⵣⵓⵏⴷ ⵉⵙⴰⴼⴰⵔⵏ ⵏ ⵉⵎⵖⴰⵢⵏ ⴷ ⵉⵙⴰⴼⴰⵔⵏ ⵏ ⵉⵎⵖⴰⵢⵏ, ⵉⵖⵢ ⴰⴷ ⵉⵔⵏⵓ ⴰⵙⵓⵔⵙ ⵏ ⵓⴽⵏⵙⵉⵔ ⵏ ⵓⴱⵔⵓⵜⵉⵙⵜ.

9. ⵉⵙⵔⴰⴳⵏ ⵉⵜⵜⵓⵙⵏⴼⴰⵍⵏ ⵙ ⵓⵖⴰⵎⵓⵙ ⵏ ⵜⴱⵔⵉⵜ: ⵉⵔⴳⴰⵣⵏ ⵏⵏⴰ ⵖⵓⵔⵙⵏ ⵉⵣⵔⵉⵏ ⵉⵙⵔⴰⴳⵏ ⵉⵜⵜⵓⵙⵏⴼⴰⵍⵏ ⵙ ⵓⵖⴰⵎⵓⵙ ⵏ ⵜⴱⵔⵉⵜ, ⵣⵓⵏⴷ ⵓⴱⴰⵢⵢⵓⵕ ⵏ ⵓⴱⵍⴽⵉⵎ ⵏⵖⴷ ⵛⵍⴰⵎⵉⴷⵢⴰ, ⵖⵉⵏ ⴰⴷ ⵖⵓⵔⵙⵏ ⵜⵉⵍⵉ ⵜⵉⵍⵉⵜ ⵉⴳⴳⵓⵜⵏ ⵏ ⵓⴱⴰⵢⵢⵓⵕ ⵏ ⵓⴱⵔⵓⵜⵉⵙⵜ.

10. ⵜⵉⵍⴰⵍⵜ ⵜⴰⵡⵜⵎⴰⵢⵜ: ⴷⴰ ⵜⵜⵉⵏⵉⵏ ⴽⵔⴰ ⵏ ⵜⵣⵔⴰⵡⵉⵏ ⵉⵙ ⵖⵓⵔ ⵉⵔⴳⴰⵣⵏ ⵏⵏⴰ ⵖⵓⵔ ⵉⵍⵍⴰ ⵓⵟⵟⵓⵏ ⴰⵎⵇⵇⵔⴰⵏ ⵏ ⵜⵎⵖⴰⵔⵉⵏ ⵏ ⵜⵍⴰⵍⵜ ⵏⵖⴷ ⵏⵏⴰ ⵉⵜⵜⵓⵙⴽⴰⵔⵏ ⵜⵉⵍⴰⵍⵜ ⵜⴰⵡⵜⵎⴰⵢⵜ ⴽⵉⴳⴰⵏ, ⵖⵓⵔⵙⵏ ⵜⵉⵍⴰⵍⵜ ⵜⴰⵡⵜⵎⴰⵢⵜ ⵏ ⵓⴳⴳⵓⴳ ⵏ ⵓⴱⴰⵢⵢⵓⵕ ⵏ ⵓⴱⵔⵓⵜⵉⵙⵜ.

11. ⴰⴱⵔⵉⴷ ⵏ ⵓⵙⵙⵉⴷⵔ: ⵉⵔⴳⴰⵣⵏ ⵏⵏⴰ ⵉⵜⵜⵓⵙⴽⵔⵏ ⴰⴱⵔⵉⴷ ⴰⴷ ⵖⵓⵔⵙⵏ ⵜⵉⵍⵉ ⵢⴰⵜ ⵜⴰⵣⵎⵔⵜ ⵜⴰⵎⵔⵏⵉⵡⵜ ⵏ ⵓⴱⴰⵢⵢⵓⵕ ⵏ ⵓⴽⵏⵙⵉⵔ ⵏ ⵓⴱⵔⵓⵜⵉⵙⵜ.

12. ⴰⵟⵟⴰⵏ: ⵉⵔⴳⴰⵣⵏ ⵉⵍⴰⵏ ⴰⵟⵟⴰⵏ ⵣⵎⵔⵏ ⴰⴷ ⵖⵓⵔⵙⵏ ⵢⵉⵍⵉ ⵓⵙⵎⵓⵙⵙⵓ ⵉⴳⴳⵓⵜⵏ ⵏ ⵓⴱⴰⵢⵢⵓⵕ ⵏ ⵓⴱⵔⵓⵜⵉⵙⵜ, ⵙⵍⴰⵡⴰⵏ ⴰⴽⴽⵡ ⵜⴰⵍⵖⵉⵡⵉⵏ ⵜⵉⴱⵓⵖⵍⴰⵏⵉⵏ ⵏ ⵜⵎⴰⴹⵓⵏⵜ.

ⵉⵇⵇⴰⵏⴷ ⴰⴷ ⵏⵙⵙⴽⵜⵉ ⵎⴰⵙ ⴷ ⵜⵉⵍⵉⵜ ⵏ ⵢⴰⵏ ⵏⵖ ⴽⵉⴳⴰⵏ ⵏ ⵉⵎⵙⴽⴰⵔⵏ ⵏ ⵓⵡⵓⵔⵔⵉ ⴳ ⵓⴱⴰⵢⵢⵓⵕ ⴰⴷ ⵓⵔ ⴷⴰ ⵉⵜⵜⵉⵏⵉ ⵙ ⵓⵖⵉⵍⵓⴼ ⵎⴰⵙ ⵔⴰⴷ ⵢⴰⵡⵉ ⵓⵔⴳⴰⵣ ⴽⴰⵏⵚⵉⵔ ⵏ ⵓⴱⴰⵢⵢⵓⵕ ⵏ ⵜⵓⵔⵉⵏ, ⴷ ⵓⵔ ⵖⵓⵔⵙ ⴽⵉⴳⴰⵏ ⵏ ⵉⵔⴳⴰⵣⵏ ⵉⵍⴰⵏ ⴽⴰⵏⵚⵉⵔ ⵏ ⵜⵓⵔⵉⵏ ⵉⵎⵙⴽⴰⵔⵏ ⵏ ⵓⵡⵓⵔⵔⵉ ⴳ ⵓⴱⴰⵢⵢⵓⵕ ⴰⴷ.

ⵎⴰⵛⴰ, ⴰⵙⵓⵙⵙⵏ ⵙ ⵉⵎⵙⴽⴰⵔⵏ ⴰⴷ ⵏ ⵓⵡⵇⵇⵕ ⵉⵖⵢ ⴰⴷ ⵢⴰⵡⵙ ⵉⵔⴳⴰⵣⵏ ⴳ ⵓⵙⵜⴰⵢ ⵏ ⵓⵙⵙⴼⵍⴷ ⴷ ⵓⵃⵟⵟⵓ.

['ⵉⵙⵓⵎⴰⵔ']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Hosseini M, SeyedAlinaghi S, Mahmoudi M, McFarland W: A case-control study of risk factors for prostate cancer in Iran. Acta Med Iran. , 48 (1): 61-6.

Oderda M, Mondino P, Zitella A, Gontero P, Tizzani A: [Update on epidemiology and risk factors of prostate cancer]. Urologia. , 75 (3): 143-8.

Mazdak H, Mazdak M, Jamali L, Keshteli AH: Determination of prostate cancer risk factors in Isfahan, Iran: a case-control study. Med Arh. 2012, 66 (1): 45-8.

Brasso K: [Prostate cancer--incidence and risk factors]. Ugeskr Laeger. 2007, 169 (20): 1883-6.

Patel AR, Klein EA: Risk factors for prostate cancer. Nat Clin Pract Urol. 2009, 6 (2): 87-95.

Sawada N: Risk and preventive factors for prostate cancer in Japan: The Japan Public Health Center-based prospective (JPHC) study. J Epidemiol. 2017, 27 (1): 2-7.

Mordukhovich I, Reiter PL, Backes DM, Family L, McCullough LE, O'Brien KM, Razzaghi H, Olshan AF: A review of African American-white differences in risk factors for cancer: prostate cancer. Cancer Causes Control. 2011, 22 (3): 341-57.

['ⴰⵙⴱⴷⵉⴷ: ⴰⵎⵙⵏⵉⵊⵊⵉ']

['ⴰⵙⵉⵜ ⴰⴷ ⵉⵜⵜⵓⴼⴽⴰ ⵖⴰⵙ ⵉ ⵓⵡⵜⵜⴰⵙ ⵏ ⵓⵙⵙⵍⵎⴷ ⴷ ⵓⵙⵏⵖⵎⵙ, ⵓⵔ ⵉⴳⵉ ⴰⵙⴼⴽ ⵏ ⵓⵎⵛⴰⵡⴰⵕ ⵏ ⵓⴷⵓⵙⵜⵓⵔ ⵏⵖⴷ ⵜⵡⵓⵔⵉⵡⵉⵏ ⵜⵉⵣⵣⵓⵍⴰⵏⵉⵏ.']

['ⵓⵔ ⵉⵇⵇⵉⵏ ⴰⴷ ⵉⵜⵜⵓⵙⵎⵔⵙ ⵓⵎⵍⴰⵏ ⵉⵜⵜⵓⴼⴽⴰⵏ ⴳ ⵓⵙⵎⵔⵙ ⵏ ⵓⵙⵎⵉⴳⵍ ⵏⵖⴷ ⵓⵙⵓⵊⵊⵉ ⵏ ⵜⵎⵓⴽⵔⵉⵙⵜ ⵏ ⵜⴷⵓⵙⵉ ⵏⵖⴷ ⵜⵎⴰⴹⵓⵏⵜ, ⴷ ⵡⵉⵏⵏⴰ ⵉⵔⴰⵏ ⴰⵙⵇⵇⵙⵉ ⴰⵎⵙⵏⵉⵊⵊⵉ ⴰⵡⵏ ⵉⵜⵜⵓⴼⴽⴰⵏ ⵉⵇⵇⴰⵏ ⴰⴷ ⵙⴰⵡⵍⵏ ⴷ ⵓⵎⵙⵏⵉⵊⵊⵉ ⵉⵜⵜⵓⵥⵍⴰⵢⵏ.']

['ⵙ ⵡⴰⵍⵍⵍⵉ ⵉⵜⵜⵓⵢⴰⵏⵏⴰ, ⵜⴰⵔⴰⵜⵙⴰ ⵏ ⵓⵏⵢⵓⵔⴰⵍ ⵏⵏⴰ ⵉⵜⵜⴰⴽⴽⴰⵏ ⵜⵉⵎⵔⴰⵔⵓⵜⵉⵏ ⵉ ⵉⵙⵇⵙⵉⵜⵏ, ⵓⵔ ⴷⴰ ⵜⵜⵉⵍⵉ ⴰⴽⴽⵡ ⵜⵓⵙⴷⵉⴷⵜ ⴳ ⵎⴰⴷ ⵉⵥⵍⵉⵏ ⵙ ⵓⵡⵏⵖ ⵏ ⵓⵟⵟⵓⵏ. ⵙ ⵓⵎⴷⵢⴰ, ⵓⵟⵟⵓⵏ ⵏ ⵎⴷⴷⵏ ⵉⵜⵜⵓⵙⵏⴼⴰⵍⵏ ⵖⴼ ⵜⵎⴰⴹⵓⵏⵜ ⵉⵥⵍⵉⵏ.']

['ⵚⵓⴰⵍ ⵙⵓⵍ ⴰⵙⵏⴰⵍ ⵏ ⵓⵊⵉⵊⵊⵉ ⵏⵏⴽ ⵏⵖⴷ ⴽⵔⴰ ⵏ ⵓⵎⵙⵙⵉⵡⵍ ⵏ ⵜⴷⵓⵙⵉ ⵢⴰⴹⵏ ⵉⵇⴱⵍⵏ ⴳ ⵎⴰⴷ ⵉⵥⵍⵉⵏ ⵙ ⵡⴰⴷⴷⴰⴷ ⵏ ⵜⴷⵓⵙⵉ. ⵓⵔ ⴰⴽⴽⵡ ⴰⴷ ⵜⵙⵙⴼⵍⴷ ⴰⵙⵏⴰⵍ ⵏ ⵓⵊⵉⵊⵊⵉ ⴰⵣⵣⵓⵍⴰⵏ ⵏⵖⴷ ⴰⴷ ⵜⵣⴰⵢⴷ ⴳ ⵓⵙⵓⵜⴳ ⵏⵏⵙ ⴰⵛⴽⵓ ⵏⵜⵜⴰⵜ ⴰⵢⴷ ⵜⵙⵙⵖⵔⴷ ⴳ ⵓⵙⵉⵜ ⴰⴷ. ⵎⴽ ⵜⵓⵔⴷⴰ ⴰⴷ ⵖⵓⵔⴽ ⵉⵍⵍⴰ ⵡⴰⴷⴷⴰⴷ ⵏ ⵜⴷⵓⵙⵉ ⵉⵣⵣⴳⵔⵏ, ⵙⵎⴷ 911 ⵏⵖⴷ ⴰⴷ ⴷⵉⴷⵜ ⵜⴰⵍⵙ ⴷⴰⵔ ⵜⴰⴷⴰⵍⴰ ⵏ ⵓⵣⵣⵔⴰⵢ ⵏ ⵣⵉⴽⴽ. ⵓⵔ ⵜⵍⵍⴰ ⵜⵓⵇⵇⵏⴰ ⵏ ⵓⵊⵉⵊⵊⵉ ⴷ ⵓⵎⵏⵉⴳ ⵙ ⵓⵙⵉⵜ ⴰⴷ ⵏⵖⴷ ⵓⵙⵎⵔⵙ ⵏⵏⵙ. ⵓⵔ ⴷⴰ ⵜⵙⴽⴰⵔ ⴱⵢⵓⵎⵉⴷⵍⵉⴱ ⵏⵖⴷ ⵉⵎⵙⵡⵓⵔⵉⵏ ⵏⵏⵙ ⵏⵖⴷ ⴽⵔⴰ ⵏ ⵓⵎⴷⵔⴰⵡ ⴳ ⵓⵙⵉⵜ ⴰⴷ ⴽⵔⴰ ⵏ ⵓⵙⵎⴷⵢⴰ, ⵙ ⵡⴰⵡⴰⵍ ⵏⵖⴷ ⵙ ⵓⵙⵏⵓⵎⵍ, ⴳ ⵎⴰⴷ ⵉⵥⵍⵉⵏ ⵙ ⵉⵏⵖⵎⵉⵙⵏ ⵉⵍⵍⴰⵏ ⴳ ⵓⴷⵖⴰⵔ ⴰⴷ ⵏⵖⴷ ⵓⵙⵎⵔⵙ ⵏⵏⵙ.']

['ⴰⵙⴱⴰⴷⵓ: ⵉⵣⵔⴼⴰⵏ ⵏ ⵓⴼⵓⵙ']

['ⴰⵛⵔⵓⵜ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ']

['ⵎⴽ ⵜⵛⵛⵉⵖⴰⵍⴷ ⵙ ⵜⵛⵛⵉⵢⵜ ⵎⴰⵙⴷ ⴽⵔⴰ ⵏ ⵜⵓⵎⴰⵢⵜ ⵏⵖⴷ ⵉⵙⵏⴼⴰⵔⵏ ⵏⵏⴰ ⵉⵜⵜⵓⴼⴽⴰⵏ ⴳ ⵡⴰⵙⵉⵜ ⵏⵏⵓⵏ ⵏⵖⴷ ⵜⵉⵙⵏⵙⵉ ⵏⵏⵓⵏ ⴷⴰ ⵉⴽⵛⵎⵏ ⴳ ⵉⵣⵔⴼⴰⵏ ⵏ ⵓⵣⵔⴼ ⵏⵏⵓⵏ, ⵜⵣⵎⵔⴷ ⴰⴷ ⵜⴰⵍⵙⴷ (ⵏⵖ ⴰⵎⴷⵢⴰⵣ ⵏⵏⴽ) ⴰⴷ ⵜⵙⵏⵎⵍⴷ ⵉ ⵡⴰⵙⵉⵜ ⵏⵏⵓⵏ ⵙ ⵓⵙⵓⵜⵔ ⵏ ⵓⵙⵙⵉⴷⴼ ⵏ ⵜⵓⵎⴰⵢⵜ ⵏⵖⴷ ⵉⵙⵏⴼⴰⵔⵏ, ⵏⵖⴷ ⴰⴷ ⵜⴱⴷⴷⴷ ⵜⵉⵍⵉⵜ ⵏⵏⵙⵏ.']

['ⵉⵏⴰⵓⴰⵏ ⴰⵂⴰⵏ ⴰⴾⵜⴰⴱ ⵙ ⴰⵍⴾⵉⵜⵜⴰⴱ ⵙ ⵎⵢⵍ (ⵉⴾⵉⴰⴷ ⵙ ⴰⴾⵜⴰⴱ "ⵎⵢⵍ" ⵉ ⵎⵢⵍ)']

['DMCA ⵜⵙⵙⵓⵜⵔ ⴰⵙⵎⵉⵙⵉ ⵏⵏⴽ ⵏ ⵓⵎⴳⴰⵍ ⵏ ⵉⵣⵔⴼⴰⵏ ⵏ ⵓⵎⴳⴰⵢ ⵉⴽⵛⵎ ⴳ ⵓⵙⵎⵎⴰⵍ ⴰⴷ: (1) ⴰⵙⵏⵓⵎⵍ ⵏ ⵜⵡⵓⵔⵉ ⵉⵃⴱⴰⵏ ⵉⵣⵔⴼⴰⵏ ⵏ ⵓⵎⴳⴰⵢ ⵏⵏⴰ ⵉⴳⴰⵏ ⴰⵙⵏⵜⵍ ⵏ ⵓⵎⴳⴰⵍ; (2) ⴰⵙⵏⵓⵎⵍ ⵏ ⵜⵓⵎⴰⵢⵜ ⵉⵃⴱⴰⵏ ⵉⵣⵔⴼⴰⵏ ⴷ ⵉⵏⵖⵎⵉⵙⵏ ⵉⵅⵚⵚⴰⵏ ⴰⴼⴰⴷ ⴰⴷ ⵏⴰⴼ ⵜⵓⵎⴰⵢⵜ; (3) ⵉⵏⵖⵎⵉⵙⵏ ⵏ ⵓⵎⵢⴰⵡⴰⴹ ⴰⴽⴷⴽ, ⴳ ⵉⵍⵍⴰ ⵡⴰⵏⵙⴰ ⵏⵏⴽ, ⵓⵟⵟⵓⵏ ⵏ ⵜⵉⵍⵉⴼⵓⵏ ⴷ ⵡⴰⵏⵙⴰ ⵏ ⵓⵍⵉⴽⵜⵕⵓⵏ; (4) ⴰⵙⵉⵡⴹ ⵏⵏⴽ ⵎⴰⵙ ⴷⴰⵔⴽ ⵜⴰⵍⵍⵉⵍⵜ ⵉⵖⵓⴷⴰⵏ ⵏ ⵓⵙⵏⴽⴷ ⵎⴰⵙ ⵜⵓⵎⴰⵢⵜ ⵙ ⵜⵖⴰⵔⴰⵙⵜ ⵏⵏⴰ ⵜⵙⵙⵔⴳⴰⵍ ⵓⵔ ⵜⴽⴽⵉ ⵜⵓⵔⴰⴳⵜ ⵙⴳ ⵖⵓⵔ ⵡⴰⵏⵏⴰ ⵉⵟⵟⴰⴼⵏ ⵉⵣⵔⴼⴰⵏ ⵏ ⵓⵎⴳⴰⵢ, ⵏⵖⴷ ⴰⵎⴷⵢⴰⵣ ⵏⵏⵙ, ⵏⵖⴷ ⵙ ⵓⵙⵡⵓⵔⵉ ⵏ ⴽⵔⴰ ⵏ ⵓⵙⵍⴳⵏ; ']

['(5) ⴰⵙⵉⵙⵙⵉⴾⵉ ⵏⵢⵜ, ⵉⴾⴼⴰⵏ ⵙ ⴰⵍⵆⴰⴾⵓⵎ ⵏ ⴰⵍⵆⴰⴾⵓⵎ ⵏ ⵜⵉⴷⵉⵜ, ⴰⵙ ⵉⵙⴰⵍⴰⵏ ⵓⵉⵏ ⵢⵎⵢⵍ ⵏⴰⵙⴰⵏ ⵓⵉⵏ ⵢⵎⵢⵍ ⵓⵉⵏ ⴰⴾⴰⵉⴰⴷ ⴷ ⴰⵙ ⵉⵍⴰ ⴰⴾⴰⵉⴰⴷ ⵉ ⴰⵙⵓⵋ ⵏ ⴰⵍⵆⴰⴾⵓⵎ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵜⵉⵏ ⴰⴾⴰⵉⴰⴷ ⵓⵉⵏ ⴰⴾⴰⵉⴰⴷ ⵓⵉ ⴰⵋⵋⴰⵏⵢⵏ']

['ⴷ (6) ⴰⴾⴰⵔⵓⵙ ⵏ ⵉⴾⵉⵜⴱⴰⵏ ⵏ ⵎⵓⵙⵏⴰⵜ ⵏ ⵉⴾⵉⵜⴱⴰⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜ ⵎⵢⵗ ⵓⴰ ⵉⵋⵋⴰⵏ ⵙ ⵢⵎⵢⵍ ⵏ ⵎⵓⵙⵏⴰⵜ ⵏ ⵉⴾⵉⵜⴱⴰⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜ']

['ⴰⴾⴰⵉⴰⴷ ⵏ ⴰⵙⴰⴾⵏⵢ ⵏ ⵉⵙⴰⵍⴰⵏ ⵓⵉⵏ ⴰⵋⵋⵓⵜⵏⵢⵏ ⴰⴷⴷⵓⴱⴰⵜ ⴰⴷ ⵢⵈⵈⵉⵍ ⴰⵙⵉⵓⴰⴷ ⵏ ⴰⴾⴰⵉⴰⴷ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜ ⵏⵢⵜ']

['ⴰⵎⵢⴰⵡⴰⴹ']

['ⵙⵓⴾⵢⵍ ⵉⵢⵎⴰⵍ ⵉⵢⵎⴰ ⵙ ⴽⴰⴾⴰⵎⴰⵍ ⴰⵙⵉⵙⵜⴰⵏ/ⴰⵙⵓⵋ']

What are the risk factors for prostate cancer?

1. Age: The risk of prostate cancer increases with age, with most cases occurring in men over the age of 65.

2. Race/Ethnicity: African American men have a higher risk of developing prostate cancer than men of other races.

3. Family History: Men with a family history of prostate cancer, particularly a father or brother with the disease, have a higher risk.

4. Genetics: Certain inherited genetic mutations, such as BRCA1 and BRCA2, may increase the risk of prostate cancer.

5. Diet: A diet high in red meat and low in fruits and vegetables may increase the risk of prostate cancer.

6. Obesity: Being overweight or obese may increase the risk of prostate cancer, particularly aggressive forms of the disease.

7. Smoking: Smoking may increase the risk of prostate cancer, particularly advanced or fatal forms of the disease.

8. Chemical Exposure: Exposure to certain chemicals, such as pesticides and herbicides, may increase the risk of prostate cancer.

9. Sexually Transmitted Infections: Men with a history of sexually transmitted infections, such as gonorrhea or chlamydia, may have an increased risk of prostate cancer.

10. Sexual Activity: Some studies suggest that men who have a higher number of sexual partners or engage in frequent sexual activity may have a slightly increased risk of prostate cancer.

11. Vasectomy: Men who have had a vasectomy may have a slightly increased risk of prostate cancer.

12. Diabetes: Men with diabetes may have a higher risk of prostate cancer, particularly aggressive forms of the disease.

It is important to note that having one or more of these risk factors does not necessarily mean that a man will develop prostate cancer, and many men with prostate cancer have no known risk factors.

However, being aware of these risk factors can help men make informed decisions about screening and prevention.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.

['ⴰⵜⵜⴰⵢⵏ']

['ⴷⴰ ⵉⵙⵙⵎⵔⴰⵙ ⴱⵢⵓ ⵎⵉⴷⵍⵍⵉⴱ ⵉⵎⴰⵙⵙⵏ ⵏ ⵓⵙⵉⴳⴳⵍ ⵉⵎⵉⴽⵙⵉⵍⵏ (ⴰⵍⴳⵓⵔⵉⵜⵎ ⵏ ⵓⵍⵎⵎⵓⴷ ⵏ ⵉⵎⵉⵙ) ⵉ ⵓⵙⵓⴼⵖ ⵏ ⵉⵎⵣⵉⵏⵏ ⵏ ⵉⵙⵇⵙⵉⵜⵏ ⴷ ⵜⵎⵔⴰⵔⵓⵜⵉⵏ.']

['ⴷⴰ ⵏⵙⵙⵏⵜⵉ ⵙ 35 ⵎⵍⵢⵓⵏ ⵏ ⵜⵥⵕⵉⴳⵉⵏ ⵏ ⵜⵙⵏⵉⵊⵊⵉⵜ ⵜⴰⴱⵢⵓⵎⵉⴷⵉⴽⵜ ⵏ ⴱⴰⴱⵎⵉⴷ/ⵎⵉⴷⵍⵉⵏ. ⵓⵍⴰ ⴰⵡⴷ ⵜⵉⴼⵔⴽⵉⵏ ⵏ ⵡⵉⴱ ⵏ ⵔⴰⴼⵉⵏⴷⵡⵉⴱ.']

['ⴰⵜ-ⵓ-ⴰⵗ "ⴰⵍⵓⴰⵈⴰⵏ" ⴰⴷ "ⴰⴾⴼⴰⵣ"']